Hints and tips:
Related Special Reports
...Under such “risk-based contracts”, healthcare providers could spread the cost over a longer period during which they could see savings, for example, from not having to treat as many expensive heart attacks...
...Novo Nordisk is exploring ways to spread the cost of the drugs over several years so health systems can better capture the potential cost savings from preventing expensive events such as heart attacks....
...However, it is the trial gardens by the nursery in Dedemsvaart — called Tuinen Mien Ruys — that lie at the heart of Crawford’s book....
...Dorsey’s anxiety about this power — and the question of what happens when Elon Musk wields it — lies at the heart of Wagner’s book....
...A new study shows that popular weight loss drug Wegovy can also reduce the risk of a heart attack or stroke by 20 per cent....
...We can actually regenerate the tissues that are lost — beta cells for diabetes, dopaminergic neurons for Parkinson’s disease, beating heart cells for heart failure.”...
...The guitar is like your heart strings, it’s your soul. You hug it in a way that [turns it into] an extension of your body and you feel the frequency of the sound you’re making in your stomach....
...At its heart, Breaking Twitter illustrates the dangers of ego and perpetuating a culture of fear. By journalistic standards, it is unclear exactly how much creative licence Mezrich has taken....
...Obesity will affect an estimated 1bn people by 2030 — with all the associated impact that has on rates of diabetes, heart disease and mobility....
...The full data was announced at an American Heart Association congress and published in the New England Journal of Medicine....
...Initial trial data published in August showed that Wegovy lowered the risk of a serious cardiac event such as a heart attack or stroke by 20 per cent....
...“The heart of that is really making sure that a rebate restores the UK to a more reasonable relative position compared to other similar countries.”...
...Novo Nordisk’s obesity drug cuts the risk of major cardiovascular events such as heart attacks or strokes by 20 per cent compared with a placebo, bolstering the Danish drugmaker’s case that health systems...
...For example, it recently calculated that it could cost $1.1mn for Wegovy, the Novo Nordisk drug, to prevent one heart attack, stroke or cardiovascular death. Novo Nordisk did not comment....
...Novo Nordisk published data in August that showed Wegovy cut the risks of cardiovascular events such as heart attacks or strokes, prompting shares to soar as much as 16 per cent....
...Sufferers can have heart problems, diabetes and disorders of the nervous system....
...significantly better than for the primary series of vaccines given during the pandemic, and that the combined shot would be targeted at older people who were not at risk of the serious but rare side effect of a heart...
...The recent positive results from its study of the impact of Wegovy on heart conditions, which came on the same day as very strong earnings from its rival Eli Lilly, changed the game, she added....
...Novo Nordisk’s best-selling obesity drug cuts the risk of heart attacks or strokes, according to the findings of a late-stage trial that sent shares in the Danish pharmaceutical company and its main rival...
...The management team were debating whether to embark on an expensive trial that would prove whether or not Wegovy would cut the risk of heart attacks and strokes....
...Shares in Novo rose to a record high this week after the company published headline data from a trial that showed its obesity drug cut the risk of serious cardiac events such as heart attacks and strokes...
...This last relationship is at the heart of this staging: the bond between the two is clearly something more than friendship....
...Angel Heart (1987), too, associates an incestuous relationship with hell: once he has soiled the most sacred of bonds, albeit unwittingly, Mickey Rourke’s protagonist can neither deny nor evade his damnation...
...In a trial of patients with obesity and cardiac conditions, Wegovy was shown to cut the risk of serious events such as heart attacks and strokes by 20 per cent, proving that the drug improves heart health...
...Farxiga, a drug for type 2 diabetes, chronic kidney disease and heart failure, became the company’s biggest seller for the first time in the quarter, with sales up 41 per cent at constant exchange rates,...
International Edition